PACTR201602001475928Other未知
Optimized letrozole dose versus traditional use of clomiphene citrate in induction of ovulation in patients with PCOS a prospective randomized controlled trial (OLDVCCI)
Minia Maternity Hospital0 sites210 target enrollmentStarted: February 16, 2016Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Other
- Sponsor
- Enrollment
- 210
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 Year(s) to 34 Year(s) (—)
- Sex
- Female
Inclusion Criteria
- •¿ Patent fallopian tubes proved by hysterosalpingography .
- •¿their partners had normal semen analysis parameters according to the modified criteria of the World Health Organization.
- •¿Age 18 ¿ 34 years
Exclusion Criteria
- •¿Combined factors of infertility
- •¿Ovarian cyst
- •¿Previous ovarian laparoscopic drilling.
Investigators
Similar Trials
Recruiting
Phase 2
etrozole for IUIIRCT20220412054511N1Shahid Beheshti University of Medical Sciences80
Recruiting
Phase 3
Study of extended Letrozole treatment protocol (7 and 10 days) on the ovulation induction and clinical pregnancy in conventional treatment-resistant (5 days) Poly Cystic Ovary Syndrome patientsInfertility.Female infertilityIRCT20110908007513N19Esfahan University of Medical Sciences66
Completed
Phase 2
Evaluation of the usefulness of letrozole as neoadjuvant hormone therapy for postmenopausal patients with hormone receptor-positive breast cancerBreast cancerJPRN-UMIN000003699St. Luke's International Hospital60
Completed
Phase 2
Evaluation of efficacy of Letrozole on the duration and severity of Ovarian hyperstimulation syndromeIRCT20141008019464N2Kerman University of Medical Sciences40
Not yet recruiting
Phase 3
etrozole effect in IVF cyclesPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20150105020558N3Tehran University of Medical Sciences510